Key points are not available for this paper at this time.
MP-CPC is an effective treatment for patients with refractory glaucoma. Shorter treatment times with more frequent repeat treatments, if necessary, should be considered given the incidence of significant vision loss in this study.
Williams et al. (Fri,) studied this question.